Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2004

View Archived Issues

Sepracor highlights year-end 2003 progress

T-0901317 induces severe lipogenesis in diabetic mice

Novel selective cytokine inhibitory drugs demonstrate enhanced antiangiogenic activity

Novel protease inhibitor SM-322377 active against multidrug-resistant HIV variants

Cleveland Clinic and Ricerca to develop cobalamin-based anticancer compound

SU-11248 inhibits tumor growth and osteolysis in a human breast cancer bone metastasis model

Altana researchers present two novel series of PARP-1 inhibitors

Procter & Gamble claims ICE inhibitors for bone disorders and other uses

GSK scientists identify new cathepsin K/falcipain inhibitors

Takeda patent covers novel tachykinin antagonists with utility in urinary disorders

New antitumor agents developed by RIKEN scientists

NO-containing COX-2 inhibitors in early development at NitroMed

Glycine transport inhibitors from bacterial source and their use in ataxia

Merck and Jerini to develop small molecule inhibitors for cancer

Tanabe gains Japanese rights to prasterone

Pfizer submits sNDA for Geodon product label changes

NeoRx receives payment from Boston Scientific

Rapid absorption, high plasma concentrations in phase I nasal fentanyl study

Activa Therapy more effective than pallidotomy in Parkinson's patients

Betaseron prefilled diluent syringe launched in U.S.

Phase III Thymitaq trial cleared to continue by DSMB

Lilly reacts to opinion paper on antipsychotic drugs in obesity and diabetes

Initial proof-of-concept study successfully completed for Provasca

Rigel reports on the progress of R-803, R-406

European orphan drug status for sildenafil for PAH

Provectus prepares IND filing for Provecta

Launch of Zoderm acne treatment

Xcytrin enters phase I trial in combination with Temodar for glioma

Viral Therapeutics acquires development rights to Virusorb

Lipid profile improvements found with D-003 in patients with type II hypercholesterolemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...